Pegloticase in Combination With Methotrexate Improves Therapeutic Response in Uncontrolled Gout
Researchers examined the efficacy and safety of pegloticase in combination with methotrexate in patients with uncontrolled gout.
All articles by Emily Pond
Adverse Event Profile of Nintedanib in SSc-ILD Consistent With its Safety, Tolerability Profile in Idiopathic Pulmonary Fibrosis
Researchers characterized the safety and tolerability of nintedanib and the dose adjustments for adverse events in patients with systemic sclerosis-associated interstitial lung disease.
New Composite Disease Activity Score Assesses Systemic Manifestations of Juvenile Idiopathic Arthritis
An international panel of pediatric rheumatologists created a new score to address a lack in the 4-item JADAS in quantifying the burden of extra-articular manifestations of juvenile idiopathic arthritis.
Genetic Risk Scores May Facilitate Clinical Diagnosis of Juvenile Idiopathic Arthritis
Researchers evaluated the use and performance of genomic risk scores for the clinical diagnosis of juvenile idiopathic arthritis.
New SLE Classification Criteria Perform Well in Early Disease and Across Sexes, Ethnicities
Researchers evaluated the performance of 2019 EULAR/ACR classification criteria for systemic lupus erythematosus, with regard to disease duration, sex, and race/ethnicity.
Treatment With Hydroxychloroquine Plus Azithromycin Linked to Cardiovascular Mortality in Rheumatoid Arthritis
Researchers assessed the safety of hydroxychloroquine alone and in combination with azithromycin to determine the risk associated with its use in routine care in rheumatoid arthritis.
Phenotype of COVID-19-Associated Hyperinflammation Linked to Escalation of Respiratory Support, Survival
Researchers evaluated a specific phenotype of COVID-19-associated hyperinflammation and its association with escalation of patient care.
Vitamin D Deficiency Associated With Increased Inflammatory Activity in Spondyloarthritis
Researchers evaluated the association between vitamin D deficiency and inflammatory activity in patients with spondyloarthritis.
Serious Infection Risk Not Significantly Higher With Denosumab vs Alendronate in Osteoporosis
Researchers assessed the serious infection risk for denosumab vs alendronate in real-world practice.
Increased Osteoporotic Fracture Risk Among Patients With RA Receiving Oral Glucocorticoids and Proton Pump Inhibitors
Researchers assessed the association between concomitant use of oral glucocorticoids and proton pump inhibitors and osteoporotic fracture risk in rheumatoid arthritis.
-
Loading...
-
Loading...
Next post in ASBMR 2020
